Wang recieves grant from Gabrielle's Angel Foundation for Cancer Research

Greg Wang, PhD, assistant professor of biochemistry and biophysics, received a grant to study "Novel Approaches to Target PRC2 Enzymatic Complexes for the Treatment of Hematopoietic Malignancies."

Wang recieves grant from Gabrielle's Angel Foundation for Cancer Research click to enlarge Greg Wang, PhD

The purpose of Gabrielle's Angel Foundation is "to encourage the development of more effective therapies for patients with leukemia, lymphoma and related cancers." Since 1996, Gabrielle's Angel Foundation has awarded $25 million to over 130 of the nation's best and brightest junior investigators.

Wang's research involves enzymes that modify chromatin (the physiological form of DNA), which are commonly found hyper-activated in lymphoma and myeloma. Novel therapeutics need to be developed for treating these currently incurable malignancies. Working towards that end, Wang and lab members investigate the mechanisms for enzyme hyperactivities and develop new ways to inhibit them as novel cancer therapeutic inventions.

Wang is an Assistant Professor in the Department of Biochemistry and Biophysics and a member of UNC Lineberger Comprehensive Cancer Center. He completed a postdoctoral fellowship with David Allis in the laboratory of Chromatin Biology & Epigenetics at Rockefeller University in New York. Since joining the faculty at UNC, he has been awarded a UNC Jefferson Pilot Fellowship in Academic Medicine (2013) and a Martin D. Abeloff, MD V Scholar Award from the V Foundation for Cancer Research (2011). He is also currently completing a Howard Temin ‘Pathway to Independence’ Award in Cancer Research from the National Cancer Institute (2010–present). Dr. Wang is the first recipient of Dr. Janet D Rowley Medical Research Award, in memory and honor of Dr. Rowley's pioneering research career in hematological cancers. 

Gabrielle's Angel Foundation for Cancer Research